Article
Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets
15 Mar 2016
Abstract excerpt
Allogeneic stem cell transplantation (alloSCT) can be a curative treatment for hematological malignancies. Unfortunately, the desired anti-tumor or graft-versus-leukemia (GvL) effect is often accompanied with undesired side effects against healthy tissues known as graft-versus-host disease (GvHD). After HLA-matched alloSCT, GvL and GvHD are both mediated by donor-derived T-cells recognizing polymorphic peptides...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
